Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial-Reference-Cited by-同舟云学术

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Published:2015-10 Issue:13 Volume:16 Page:1324-1334
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Le Tourneau Christophe,Delord Jean-Pierre,Gonçalves Anthony,Gavoille Céline,Dubot Coraline,Isambert Nicolas,Campone Mario,Trédan Olivier,Massiani Marie-Ange,Mauborgne Cécile,Armanet Sebastien,Servant Nicolas,Bièche Ivan,Bernard Virginie,Gentien David,Jezequel Pascal,Attignon Valéry,Boyault Sandrine,Vincent-Salomon Anne,Servois Vincent,Sablin Marie-Paule,Kamal Maud,Paoletti Xavier

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing;Gerlinger;N Engl J Med,2012

2. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

3. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib;Sosman;N Engl J Med,2012

4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

5. Efficacy and safety of vismodegib in advanced basal-cell carcinoma;Sekulic;N Engl J Med,2012

Cited by 891 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts;Journal of the Formosan Medical Association;2024-09

2. Personalized Medicine: A Comprehensive Review;Oriental Journal Of Chemistry;2024-08-30

3. Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials;Cancers;2024-08-29

4. Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational study;The Oncologist;2024-08-23

5. Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study;BMJ;2024-08-20